Severe acute respiratory syndrome (SARS) is an acute infectious disease caused by the SARS-CoV coronavirus. The disease is characterized by high mortality and the ability to spread rapidly among people. The clinical picture of SARS includes acute respiratory symptoms such as cough, shortness of breath, and pneumonia, accompanied by systemic manifestations such as fever and myalgia. SARS was first described in 2003 during an outbreak in Hong Kong and quickly spread to many countries around the world, causing an international epidemic. In this regard, the disease attracted great attention from both the medical community and the general public due to alarming data on mortality and the severity of clinical manifestations.
History of the disease and interesting historical facts
The first outbreak of severe acute respiratory syndrome was reported in late 2002 in Guangdong Province, China. By early 2003, the disease had become an epidemic, affecting many countries, including Hong Kong, Vietnam, Singapore, Taiwan, and even parts of Europe and North America. It is believed that the main source of infection may have been animals such as the civet cat, popular in Chinese cuisine, which acted as carriers of the virus. The epidemic ended in 2004, with over 800 reported cases and a fatality rate of approximately 10%. The history of SARS remains a subject of study, as the disease has spurred research into coronaviruses in general, which has had an impact on the preparations for COVID-19 in particular.
Epidemiology
According to the World Health Organization (WHO), the SARS outbreak affected 29 countries and resulted in 8,098 confirmed cases with at least 774 deaths. The highest incidence was recorded in Hong Kong, where the infection spread in dense residential areas. According to some studies, the SARS outbreak confirmed the role of international population mobility in the rapid transmission of infection, which led to the active spread of the disease at the international level. The main risk groups were health workers and patients in contact with infected people.
Genetic predisposition to this disease
Genetic studies suggest that susceptibility to SARS may depend on certain genetic markers that influence the immune response. For example, variations in genes responsible for the production of interferons and other cytokines may be associated with the severity of the disease. In particular, genes such as IL-6, IL-10, and TNF-α are being studied for their role in the development of acute infections, including COVID-19. Mutations in genes associated with innate immunity may increase the risk of severe SARS in certain people, while others experience a milder form of the disease.
Risk factors for the development of this disease
There are several risk factors that increase the likelihood of becoming infected with the coronavirus that causes SARS. These include:
- Clinical contact with infected patients.
- Work in healthcare settings, especially in intensive care units.
- Visiting countries with reported outbreaks.
- Immune system status (weakened immunity due to other diseases).
- Old age, since older people are more likely to have a severe course of the disease.
- Chronic diseases of the respiratory system and cardiovascular system.
These factors make certain population groups more vulnerable to infection and the development of severe forms of the disease.
Diagnosis of this disease
Diagnosis of SARS begins with a clinical assessment and identification of the main symptoms. The most common are:
- Fever (above 38°C).
- Cough (dry or productive).
- Shortness of breath and difficulty breathing.
- Myalgia and headache.
- Fatigue.
To confirm the diagnosis, the following laboratory tests are carried out:
- Polymerase chain reaction (PCR) to detect viral RNA.
- Serological tests to detect antibodies to the virus.
- Complete blood count to assess inflammatory markers.
Radiological examinations such as chest X-ray and CT scan also play an important role in diagnosis, allowing detection of lung changes characteristic of viral pneumonia. The differential diagnosis should include other causes of acute respiratory syndrome, such as infection with other respiratory viruses, bacterial pneumonia, and allergic reactions.
Treatment
Treatment of SARS is mainly supportive and symptomatic, as there was no specific antiviral therapy available at the time of the outbreak. Treatment approaches include:
- Hospitalization for observation of the patient's condition.
- Oxygen therapy for hypoxia.
- Use of antiviral drugs (eg, ribavirin, interferons), although their effectiveness has not been proven.
- Symptomatic agents for fever relief and analgesia.
- Humidifying the air to make breathing easier.
- Use of antibacterial therapy in case of bacterial infection.
- In some cases, mechanical ventilation may be required.
Although there is no specific treatment, selected methods combined with intensive care can improve the prognosis for patients.
List of medications used to treat this disease
Among the drugs that have been discussed in the literature in the context of SARS treatment, the following can be highlighted:
- Ribavirin.
- Interferon alpha.
- Corticosteroids (for severe forms).
- Antibiotics (in case of secondary bacterial infection).
- New generation antiviral drugs (under study).
Research continues to examine the effectiveness and safety of various medications for the treatment of SARS.
Disease monitoring
Monitoring of patients with SARS includes regular assessment of clinical status, blood oxygen levels, lung function tests, and inflammatory markers. The prognosis for patients with SARS varies, but the risk of death is reduced with prompt hospitalization and comprehensive treatment. Complications may include:
- Acute respiratory distress syndrome (ARDS).
- Pulmonary insufficiency.
- Concomitant infections and pneumonia.
- Long-term lung damage.
Age-related features of the disease
Age-related patterns of SARS are due to differences in immune response. Older patients tend to have more severe forms of the disease and longer treatment times. In infants and children, milder forms of the disease may be associated with less lung damage. Research suggests that older people are more likely to experience breathing difficulties and higher mortality rates due to underlying medical conditions such as diabetes or cardiovascular disease.
Questions and Answers
- What are the main symptoms of SARS? The main symptoms include fever, cough, shortness of breath and myalgia.
- How is SARS diagnosed? Diagnosis is based on clinical symptoms and laboratory tests such as PCR and serological tests.
- What is the treatment for SARS? Treatment is mainly supportive and symptomatic, including oxygen therapy and the use of antiviral drugs.
- What is the prognosis for SARS patients? The prognosis depends on timely diagnosis and treatment, but in general the risk of death is somewhat high in severe cases.
- What are the risk factors for developing SARS? The main risk factors include contact with infected people and the presence of chronic diseases.
